1 - 25 of 34 results for author:"Moller D.E." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Mashili F.L., Austin R.L., Deshmukh A.S., Fritz T., Caidahl K., Bergdahl K., Zierath J.R., Chibalin A.V., Moller D.E., Kharitonenkov A. et al. Diabetes Metab. Res. Rev. 27:286-297(2011) · Mapped (1) |
| AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. Chen Y.Q., Kuo M.-S., Li S., Bui H.H., Peake D.A., Sanders P.E., Thibodeaux S.J., Chu S., Qian Y.-W., Zhao Y. et al. J. Biol. Chem. 283:10048-10057(2008) · UniProtKB (3) · Mapped (8) |
| Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. Zhao Y., Chen Y.Q., Bonacci T.M., Bredt D.S., Li S., Bensch W.R., Moller D.E., Kowala M., Konrad R.J., Cao G. J. Biol. Chem. 283:8258-8265(2008) · UniProtKB (1) · Mapped (3) |
| The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities. Einstein M., Akiyama T.E., Castriota G.A., Wang C.F., McKeever B., Mosley R.T., Becker J.W., Moller D.E., Meinke P.T., Wood H.B. et al. Mol. Pharmacol. 73:62-74(2008) · Mapped (1) |
| Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. Qian Y.W., Schmidt R.J., Zhang Y., Chu S., Lin A., Wang H., Wang X., Beyer T.P., Bensch W.R., Li W. et al. J. Lipid Res. 48:1488-1498(2007) · Mapped (10) |
| Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein. Castriota G., Thompson G.M., Lin Y., Scherer P.E., Moller D.E., Berger J.P. Cell Biol. Int. 31:586-591(2007) · Mapped (9) |
| Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity. Shi G.Q., Dropinski J.F., McKeever B.M., Xu S., Becker J.W., Berger J.P., MacNaul K.L., Elbrecht A., Zhou G., Doebber T.W. et al. J. Med. Chem. 48:4457-4468(2005) · UniProtKB (1) |
| Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Woods J.W., Tanen M., Figueroa D.J., Biswas C., Zycband E., Moller D.E., Austin C.P., Berger J.P. Brain Res. 975:10-21(2003) · Mapped (3) |
| Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Conarello S.L., Li Z., Ronan J., Roy R.S., Zhu L., Jiang G., Liu F., Woods J., Zycband E., Moller D.E. et al. Proc. Natl. Acad. Sci. U.S.A. 100:6825-6830(2003) · Mapped (3) |
| Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Ziouzenkova O., Perrey S., Asatryan L., Hwang J., MacNaul K.L., Moller D.E., Rader D.J., Sevanian A., Zechner R., Hoefler G. et al. Proc. Natl. Acad. Sci. U.S.A. 100:2730-2735(2003) · Mapped (2) |
| Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. Jiang G., Dallas-Yang Q., Liu F., Moller D.E., Zhang B.B. J. Biol. Chem. 278:180-186(2003) · Mapped (1) |
| Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists. Jiang G., Dallas-Yang Q., Li Z., Szalkowski D., Liu F., Shen X., Wu M., Zhou G., Doebber T., Berger J. et al. Diabetes 51:2412-2419(2002) · Mapped (2) |
| Role of AMP-activated protein kinase in mechanism of metformin action. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N. et al. J. Clin. Invest. 108:1167-1174(2001) · UniProtKB (2) |
| Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Dufresne S.D., Bjorbaek C., El-Haschimi K., Zhao Y., Aschenbach W.G., Moller D.E., Goodyear L.J. Mol. Cell. Biol. 21:81-87(2001) · Mapped (8) |
| Activation of PPARdelta alters lipid metabolism in db/db mice. Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Bergera J., Cullinan C.A., Sparrow C.P., Baffic J., Berger G.D. et al. FEBS Lett. 473:333-336(2000) · Mapped (6) |
| Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Bruning J.C., Gillette J.A., Zhao Y., Bjorbaeck C., Kotzka J., Knebel B., Avci H., Hanstein B., Lingohr P., Moller D.E. et al. Proc. Natl. Acad. Sci. U.S.A. 97:2462-2467(2000) · Mapped (8) |
| Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D., DuBois R.N., Trzaskos J.M., Dey S.K. Genes Dev. 13:1561-1574(1999) · Mapped (33) |
| Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Ventre J., Doebber T., Wu M., MacNaul K., Stevens K., Pasparakis M., Kollias G., Moller D.E. Diabetes 46:1526-1531(1997) · Mapped (4) |
| Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. Zhang B., Berger J., Zhou G., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., Moller D.E. J. Biol. Chem. 271:31771-31774(1996) · UniProtKB (1) |
| Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M.D., Moller D.E., Berger J. Biochem. Biophys. Res. Commun. 224:431-437(1996) · UniProtKB (1) · Mapped (7) |
| Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. Vidal-Puig A., Jimenez-Linan M., Lowell B.B., Hamann A., Hu E., Spiegelman B., Flier J.S., Moller D.E. J. Clin. Invest. 97:2553-2561(1996) · UniProtKB (1) · Mapped (10) |
| Ligand-binding properties of the two isoforms of the human insulin receptor. Yamaguchi Y., Flier J.S., Benecke H., Ransil B.J., Moller D.E. Endocrinology 132:1132-1138(1993) |
| Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Moller D.E., Cohen O., Yamaguchi Y., Assiz R., Grigorescu F., Eberle A., Morrow L.A., Moses A.C., Flier J.S. Diabetes 43:247-255(1994) · UniProtKB (1) |
| Human rsk isoforms: cloning and characterization of tissue-specific expression. Moller D.E., Xia C.-H., Tang W., Zhu A.X., Jakubowski M. Am. J. Physiol. 266:C351-C359(1994) · UniProtKB (3) |
| Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3. Zhu A.X., Zhao Y., Moller D.E., Flier J.S. Mol. Cell. Biol. 14:8202-8211(1994) · UniProtKB (1) |